PHARMAGREEN BIOTECH INC. Accounts Receivable
PHARMAGREEN BIOTECH INC. had Accounts Receivable of $606 as of 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current › Accounts and Financing Receivable, after Allowance for Credit Loss, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2023-08-14
- 2023-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $606.00.
- 2023-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $569.00.
- 2022-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $465.00.
- 2022-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $383.00.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current |
|---|---|
| 2023-06-30 | $606.00 10-Q · filed 2023-08-14 |
| 2023-03-31 | $569.00 10-Q · filed 2023-05-19 |
| 2022-12-31 | $465.00 10-Q · filed 2023-02-14 |
| 2022-09-30 | $383.00 10-Q · filed 2023-08-14 |
| 2022-06-30 | $316.00 10-Q · filed 2022-08-17 |
| 2022-03-31 | $70.00 10-Q · filed 2022-05-16 |
| 2021-09-30 | $290.00 10-Q · filed 2022-08-17 |